BackAnbio Biotechnology Class A Ordinary Shares Overview

Anbio Biotechnology Class A Ordinary Shares Total Current Liabilities

Anbio Biotechnology Class A Ordinary Shares's total current liabilities is $88K.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$87836.00
↓ 94.92% YoYΔ $-1.64M vs prior year quarter

Peer trimmed avg / median

Loading

Anbio Biotechnology Class A Ordinary Shares Total Current Liabilities History

Loading

Anbio Biotechnology Class A Ordinary Shares vs. peers: Total Current Liabilities Comparison

Loading

Anbio Biotechnology Class A Ordinary Shares Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Anbio Biotechnology Class A Ordinary Shares (NNNN) FAQ

The latest total current liabilities for NNNN is $88K as of December 2025. That compares with $1.7M in the prior-year period — down 94.9% year over year. Investors often review this figure alongside Anbio Biotechnology Class A Ordinary Shares's historical trend and sector peers before judging valuation or financial health.

Over the past year, NNNN's total current liabilities moved from $1.7M to $88K — a 94.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Anbio Biotechnology Class A Ordinary Shares's operating scale or balance-sheet position.

A total current liabilities figure of $88K for NNNN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NNNN's total current liabilities ($88K), review year-over-year change from $1.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.